港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

科笛-B

6.210

+0.0801.31%

成交量：52.66萬

成交額：323.60萬

市值：19.81億

市盈率：-4.06

高：6.280

開：6.000

低：6.000

收：6.130

資料載入中...

總覽公司新聞資訊公告

科笛-B12月09日主力資金流出99萬元連續5日減倉

科笛-B(02487)下跌5.01%，報7.21元/股

科笛-B盤中異動股價大跌5.01%

科笛-B12月06日遭主力拋售51萬元環比增加168.42%

科笛-B(02487)下跌5.1%，報7.44元/股

科笛-B盤中異動股價大跌5.61%報7.400港元

科笛-B(02487)下跌5.8%，報7.63元/股

科笛-B盤中異動臨近收盤股價大跌5.19%

科笛-B新藥CU-20401 II期臨牀獲顯著療效數據

科笛(02487.HK)新藥CU-20401臨牀展現出顯著且穩健療效優勢

阿斯达克财经

科笛-B(02487)：CU-20401(重組突變膠塬酶)治療頦下脂肪堆積II期臨牀試驗達到主要終點

科笛-B：CU-20401(重組突變膠原酶)治療頦下脂肪堆積II期臨牀試驗達到主要終點

格隆汇资讯

科笛-B(02487)：CU-40102(外用非那雄胺噴霧劑)及CU-30101(局部外用利多卡因丁卡因乳膏劑)中國III期臨牀試驗結果在第十九屆CDA年會發布

科笛-B(02487.HK)公佈兩產品內地III期臨牀試驗結果

阿斯达克财经

科笛-B盤中異動早盤大幅上漲6.46%

科笛-B(02487)上漲5.14%，報8.8元/股

科笛-B盤中異動急速拉昇5.14%報8.800港元

科笛-B盤中異動下午盤快速下跌5.07%

【港股通】科笛(02487)近日獲首席執行官增持股份合共5200股

科笛-B獲首席執行官兼執行董事張樂樂進一步增持股份

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02487/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02487","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02487\",,,,,undefined,":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"科笛-B","latestPrice":6.21,"timestamp":1747210103030,"preClose":6.13,"halted":0,"volume":526600,"delay":0,"floatShares":319000000,"shares":319000000,"eps":-1.5283816129737153,"marketStatus":"未開盤","change":0.08,"latestTime":"05-14 16:08:23","open":6,"high":6.28,"low":6,"amount":3235980,"amplitude":0.045677,"askPrice":6.21,"askSize":2800,"bidPrice":6.16,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-1.5283816129737153,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747272600000},"marketStatusCode":0,"adr":0,"listingDate":1686499200000,"exchange":"SEHK","adjPreClose":6.13,"openAndCloseTimeList":[[1747186200000,1747195200000],[1747198800000,1747209600000]],"volumeRatio":0.4466951683408009,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02487\",,,,,undefined,":{"symbol":"02487","floatShares":319000000,"roa":"-18.61%","roe":"-37.34%","lyrEps":-1.528382,"volumeRatio":0.4466951683408009,"shares":319000000,"dividePrice":0,"high":6.28,"amplitude":0.045677,"preClose":6.13,"low":6,"week52Low":3.64,"pbRate":"1.88","psRate":"6.55","week52High":18.26,"institutionHeld":0,"latestPrice":6.21,"committee":-0.647059,"eps":-1.5283816129737153,"divideRate":0,"volume":526600,"delay":0,"ttmEps":-1.5283816129737153,"open":6,"prevYearClose":7.08,"prevWeekClose":6.2,"prevMonthClose":6,"prevQuarterClose":6.02,"fiveDayClose":6.17,"twentyDayClose":4.19,"sixtyDayClose":5.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02487\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490710224","title":"科笛-B12月09日主力資金流出99萬元 連續5日減倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2490710224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490710224?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 16:15","pubTimestamp":1733732137,"startTime":"0","endTime":"0","summary":"12月09日, 科笛-B股价跌1.98%，报收7.44元，成交金额1078万元，换手率0.47%，振幅7.91%，量比1.54。科笛-B今日主力资金净流出99万元，连续5日净流出，上一交易日主力净流出51万元，今日环比增加94.12%。该股近5个交易日下跌3.85%，主力资金累计净流出324万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出420万元，其中净流出天数为10日。该股主力净额占比0.04%，港股市场排名2571/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161551ab69419e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161551ab69419e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2490320713","title":"科笛-B(02487)下跌5.01%，報7.21元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490320713","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490320713?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 13:55","pubTimestamp":1733723746,"startTime":"0","endTime":"0","summary":"12月9日，科笛-B(02487)盘中下跌5.01%，截至13:55，报7.21元/股，成交549.7万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/09135546159483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2490371367","title":"科笛-B盤中異動 股價大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490371367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490371367?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 13:55","pubTimestamp":1733723741,"startTime":"0","endTime":"0","summary":"2024年12月09日下午盘13时55分，科笛-B股票出现波动，股价大幅下跌5.01%。截至发稿，该股报7.210港元/股，成交量74.9万股，换手率0.24%，振幅5.93%。科笛-B股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，永泰生物-B、嘉和生物-B、云康集团涨幅较大，振幅较大的相关个股有晶泰科技、华康生物医学、永泰生物-B，振幅分别为25.30%、19.26%、18.33%。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209135541a1df8c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209135541a1df8c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2489040146","title":"科笛-B12月06日遭主力拋售51萬元 環比增加168.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489040146","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489040146?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 16:16","pubTimestamp":1733472988,"startTime":"0","endTime":"0","summary":"12月06日, 科笛-B股价跌0.52%，报收7.59元，成交金额539万元，换手率0.22%，振幅2.88%，量比0.69。科笛-B今日主力资金净流出51万元，连续4日净流出，上一交易日主力净流出19万元，今日环比增加168.42%。该股近5个交易日下跌1.93%，主力资金累计净流出226万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出321万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161704a1d8a27c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161704a1d8a27c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2488189981","title":"科笛-B(02487)下跌5.1%，報7.44元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488189981","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488189981?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 10:55","pubTimestamp":1733280917,"startTime":"0","endTime":"0","summary":"12月4日，科笛-B(02487)盘中下跌5.1%，截至10:55，报7.44元/股，成交221.1万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/04105545989354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2488900429","title":"科笛-B盤中異動 股價大跌5.61%報7.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488900429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488900429?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 09:31","pubTimestamp":1733275904,"startTime":"0","endTime":"0","summary":"2024年12月04日早盘09时31分，科笛-B股票出现波动，股价快速下挫5.61%。截至发稿，该股报7.400港元/股，成交量11.06万股，换手率0.03%，振幅2.81%。资金方面，该股资金流入6.1594万港元，流出23.8396万港元。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科笛-B股票所在的生物技术行业中，整体跌幅为0.47%。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093144971b7a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093144971b7a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2487582612","title":"科笛-B(02487)下跌5.8%，報7.63元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2487582612","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487582612?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 15:59","pubTimestamp":1732867159,"startTime":"0","endTime":"0","summary":"11月29日，科笛-B(02487)盘中下跌5.8%，截至15:59，报7.63元/股，成交745.48万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/29155945838791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2487823175","title":"科笛-B盤中異動 臨近收盤股價大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487823175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487823175?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 15:58","pubTimestamp":1732867115,"startTime":"0","endTime":"0","summary":"2024年11月29日临近收盘15时58分，科笛-B股票出现异动，股价急速下跌5.19%。截至发稿，该股报7.680港元/股，成交量92.88万股，换手率0.29%，振幅7.65%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科笛-B股票所在的生物技术行业中，整体涨幅为1.70%。科笛-B公司简介：科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112915583598e4595f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112915583598e4595f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2487376028","title":"科笛-B新藥CU-20401 II期臨牀獲顯著療效數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2487376028","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487376028?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 09:09","pubTimestamp":1732842599,"startTime":"0","endTime":"0","summary":"科笛-B（02487）发布公告，宣布其潜在1类新药CU-20401（重组突变胶原酶）在中国开展的II期临床试验已获得顶线数据，且达到了主要研究终点，结果具有统计学显著性及临床意义。该临床试验为多中心、随机、双盲及安慰剂对照试验，共入组108例受试者，分析显示低剂量和高剂量CU-20401组的治疗有效率均高于安慰剂对照组，且有效率差异具有统计学意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411293254457439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2487373113","title":"科笛(02487.HK)新藥CU-20401臨牀展現出顯著且穩健療效優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2487373113","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487373113?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 08:38","pubTimestamp":1732840680,"startTime":"0","endTime":"0","summary":"科笛(02487.HK) 公布，其潜在1类新药CU-20401 (重组突变胶原酶)于中国开展的用于治疗颏下脂肪堆积的II期临床试验已获得顶线数据。数据显示，该临床试验达到主要研究终点，结果具有统计学显著性及临床意义。分析结果显示，于有效性方面，主要疗效终点数据显示，低剂量CU-20401组和高剂量CU20401组的治疗有效率均高于安慰剂对照组，且有效率差异均具有统计学意义。次要疗效终点数据也展现出类似的疗效优势。整体上，CU-20401展现出显著且稳健的疗效优势，安全性良好。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1400454/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2487249933","title":"科笛-B(02487)：CU-20401(重組突變膠塬酶)治療頦下脂肪堆積II期臨牀試驗達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2487249933","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487249933?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 06:58","pubTimestamp":1732834724,"startTime":"0","endTime":"0","summary":"数据显示，该临床试验达到主要研究终点，结果具有统计学显著性及临床意义。整体上，CU-20401展现出显著且稳健的疗效优势，安全性良好CU-20401是一种重组突变胶原酶，其靶向肥胖、超重或其他与局部脂肪堆积相关的代谢疾病。经局部注射后，CU-20401通过降解皮下脂肪层中的细胞外基质胶原蛋白，导致脂肪细胞凋亡，预计可有效减少局部脂肪堆积。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1576","BK1161","03347","02487","BK1141"],"gpt_icon":0},{"id":"2487132443","title":"科笛-B：CU-20401(重組突變膠原酶)治療頦下脂肪堆積II期臨牀試驗達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2487132443","media":"格隆汇资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487132443?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 06:32","pubTimestamp":1732833131,"startTime":"0","endTime":"0","summary":"格隆汇11月29日丨科笛-B发布公告，集团的潜在1类新药CU-20401于中国开展的用于治疗颏下脂肪堆积的II期临床试验已获得顶线数据。分析结果显示：于有效性方面，主要疗效终点数据显示，低剂量CU-20401组和高剂量CU20401组的治疗有效率均高于安慰剂对照组，且有效率差异均具有统计学意义。整体上，CU-20401展现出显著且稳健的疗效优势，安全性良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129063215abe6d917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129063215abe6d917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","BK1161","BK1583","02487","03347"],"gpt_icon":0},{"id":"2486353270","title":"科笛-B(02487)：CU-40102(外用非那雄胺噴霧劑)及CU-30101(局部外用利多卡因丁卡因乳膏劑)中國III期臨牀試驗結果在第十九屆CDA年會發布","url":"https://stock-news.laohu8.com/highlight/detail?id=2486353270","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486353270?lang=zh_tw&edition=fundamental","pubTime":"2024-11-28 12:12","pubTimestamp":1732767128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科笛-B 发布公告，该集团治疗雄激素性脱发产品CU-40102及用于皮肤表皮手术的CU-30101的中国III期临床试验结果在第十九届中国医师协会皮肤科医师年会暨全国美容皮肤科学大会以电子壁报形式发布。在安全性方面， CU-30101的整体安全性良好，无重度不良事件或严重不良事件发生。CU-30101的药品上市许可申请已于2024年7月获得国家药监局受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1576","BK1161","BK1583","BK4134","BK1141","III","02487"],"gpt_icon":0},{"id":"2486355335","title":"科笛-B(02487.HK)公佈兩產品內地III期臨牀試驗結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2486355335","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486355335?lang=zh_tw&edition=fundamental","pubTime":"2024-11-28 12:01","pubTimestamp":1732766460,"startTime":"0","endTime":"0","summary":"科笛-B(02487.HK) 公布，其治疗雄激素性脱发产品CU-40102以及用于皮肤表皮手术的CU-30101的中国III期临床试验结果在全国美容皮肤科学大会(CDA年会)上公布。其中，CU-40102组的受试者的顶部秃发目标区域内的总毛发计数及终毛计数相比于基线改善均显著优于安慰剂组，达到主要终点指标和主要的次要终点指标，而且疗效从第12周起开始展现。至于CU-30101，其临床试验结果显示CU-30101与Pliaglis®镇痛疗效相当，达到主要终点。两款产品的药品上市许可申请已在今年获国家药监局受理。(vc/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1400204/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02487","BK1576","BK1583","03347","BK1141"],"gpt_icon":0},{"id":"2486365983","title":"科笛-B盤中異動 早盤大幅上漲6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486365983","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486365983?lang=zh_tw&edition=fundamental","pubTime":"2024-11-28 09:31","pubTimestamp":1732757460,"startTime":"0","endTime":"0","summary":"2024年11月28日早盘09时31分，科笛-B股票出现波动，股价急速拉升6.46%。截至发稿，该股报8.730港元/股，成交量13.26万股，换手率0.04%，振幅6.95%。科笛-B股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，科笛-B、再鼎医药、云顶新耀-B涨幅较大，振幅较大的相关个股有科笛-B、九源基因、再鼎医药，振幅分别为6.95%、5.39%、5.24%。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112809310098e45086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112809310098e45086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2486620040","title":"科笛-B(02487)上漲5.14%，報8.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486620040","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486620040?lang=zh_tw&edition=fundamental","pubTime":"2024-11-26 15:53","pubTimestamp":1732607598,"startTime":"0","endTime":"0","summary":"11月26日，科笛-B(02487)盘中上涨5.14%，截至15:53，报8.8元/股，成交495.0万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/26155345687391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科笛-B(02487)上涨5.14%，报8.8元/股","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2486395025","title":"科笛-B盤中異動 急速拉昇5.14%報8.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486395025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486395025?lang=zh_tw&edition=fundamental","pubTime":"2024-11-26 15:53","pubTimestamp":1732607592,"startTime":"0","endTime":"0","summary":"2024年11月26日临近收盘15时53分，科笛-B股票出现波动，股价急速上涨5.14%。截至发稿，该股报8.800港元/股，成交量58.62万股，换手率0.18%，振幅6.09%。资金方面，该股资金流入239.875万港元，流出181.172万港元。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科笛-B股票所在的生物技术行业中，整体跌幅为0.11%。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112615531298e449a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112615531298e449a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2484969554","title":"科笛-B盤中異動 下午盤快速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484969554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484969554?lang=zh_tw&edition=fundamental","pubTime":"2024-11-19 13:49","pubTimestamp":1731995398,"startTime":"0","endTime":"0","summary":"2024年11月19日下午盘13时49分，科笛-B股票出现异动，股价大幅下挫5.07%。截至发稿，该股报8.240港元/股，成交量9.54万股，换手率0.03%，振幅4.61%。科笛-B股票所在的生物技术行业中，整体跌幅为0.04%。科笛-B公司简介：科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111913495998e436d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111913495998e436d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2484666926","title":"【港股通】科笛(02487)近日獲首席執行官增持股份合共5200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484666926","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484666926?lang=zh_tw&edition=fundamental","pubTime":"2024-11-18 08:59","pubTimestamp":1731891552,"startTime":"0","endTime":"0","summary":"于本次增持股份前，张女士于公开市场购买合共33,000股股份，总代价为约393,212港元。张女士表示，增持股份反映其对公司价值和未来发展的肯定，同时也代表其对公司的业务前景及市场潜力充满信心。在遵守适用法律及监管规定的情况下，张女士不排除考虑于适当时机进一步增持公司股份的可能性。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/ZjI2Mjk2NDJlMTg0ZTY2MjVhYzY3MmYxYmE2MzM4MDk2MjYyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZjI2Mjk2NDJlMTg0ZTY2MjVhYzY3MmYxYmE2MzM4MDk2MjYyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1947867","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","HSCEI","BK1161","HSTECH","YANG"],"gpt_icon":0},{"id":"2484666668","title":"科笛-B獲首席執行官兼執行董事張樂樂進一步增持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2484666668","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484666668?lang=zh_tw&edition=fundamental","pubTime":"2024-11-18 08:58","pubTimestamp":1731891480,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　科笛-B（02487）发布公告，公司董事会接获公司首席执行官兼执行董事张乐乐的通知，彼于2024年11月14日以其个人资金于公开市场上购买合共5200股公司股份，总代价为约4.96万港元（增持股份）。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-18/doc-incwmvkt3765326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02487"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":142,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02487\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02487","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2024-08-29","symbol":"02487","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724860800000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-27","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-29","symbol":"02487","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02487\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02487\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1744041600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02487\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02487","date":"2025-05-13","current":-4.160585,"percent":0.280255,"low":-15.485925,"twenty":-6.412794,"median":-2.992175,"eighty":-1.047676,"high":-0.826569,"avg":-3.839666,"sd":3.355443,"marketCap":1952944323},"quantilePoints":[{"date":"2023-06-16","current":-15.411162,"twenty":-14.413676,"median":-12.389874,"eighty":-12.075055,"marketCap":9394355968},{"date":"2023-06-23","current":-12.436662,"twenty":-14.898766,"median":-13.544522,"eighty":-12.376412,"marketCap":7539806732},{"date":"2023-06-30","current":-12.398371,"twenty":-14.32145,"median":-12.394122,"eighty":-11.447458,"marketCap":7448599392},{"date":"2023-07-07","current":-11.154992,"twenty":-13.792435,"median":-12.336647,"eighty":-11.411148,"marketCap":6688538230},{"date":"2023-07-14","current":-10.800615,"twenty":-12.879806,"median":-11.67313,"eighty":-11.073156,"marketCap":6566928444},{"date":"2023-07-21","current":-9.796084,"twenty":-12.413687,"median":-11.417592,"eighty":-10.790615,"marketCap":5928477067},{"date":"2023-07-28","current":-10.460353,"twenty":-12.393273,"median":-11.232297,"eighty":-10.42688,"marketCap":6323708872},{"date":"2023-08-04","current":-10.844647,"twenty":-12.36968,"median":-11.144468,"eighty":-10.471016,"marketCap":6566928444},{"date":"2023-08-11","current":-11.613111,"twenty":-12.376412,"median":-11.154992,"eighty":-10.495819,"marketCap":6992562695},{"date":"2023-08-18","current":-11.061159,"twenty":-12.34839,"median":-11.14973,"eighty":-10.533878,"marketCap":6612532113},{"date":"2023-08-25","current":-12.606042,"twenty":-12.421346,"median":-11.281516,"eighty":-10.611978,"marketCap":7539806732},{"date":"2023-09-01","current":-3.762061,"twenty":-12.421346,"median":-11.154992,"eighty":-10.467461,"marketCap":7904636090},{"date":"2023-09-08","current":-3.045502,"twenty":-12.394972,"median":-11.061159,"eighty":-10.227752,"marketCap":6323708872},{"date":"2023-09-15","current":-3.276331,"twenty":-12.381613,"median":-10.935179,"eighty":-6.512762,"marketCap":6855751685},{"date":"2023-09-22","current":-3.006155,"twenty":-12.36402,"median":-10.844647,"eighty":-3.792803,"marketCap":6262903979},{"date":"2023-09-29","current":-2.913601,"twenty":-12.34839,"median":-10.788114,"eighty":-3.305013,"marketCap":6080489300},{"date":"2023-10-06","current":-3.060747,"twenty":-12.287596,"median":-10.741943,"eighty":-3.213384,"marketCap":6384513765},{"date":"2023-10-13","current":-3.036132,"twenty":-12.066426,"median":-10.551151,"eighty":-3.148051,"marketCap":6323708872},{"date":"2023-10-20","current":-3.106604,"twenty":-11.932534,"median":-10.469238,"eighty":-3.120451,"marketCap":6460519881},{"date":"2023-10-27","current":-2.925118,"twenty":-11.796455,"median":-10.343076,"eighty":-3.068613,"marketCap":6080489300},{"date":"2023-11-03","current":-2.990305,"twenty":-11.691357,"median":-10.218458,"eighty":-3.045502,"marketCap":6232501532},{"date":"2023-11-10","current":-3.268138,"twenty":-11.654904,"median":-9.796084,"eighty":-3.060747,"marketCap":6810148016},{"date":"2023-11-17","current":-3.108791,"twenty":-11.613111,"median":-4.217909,"eighty":-3.060747,"marketCap":6536525997},{"date":"2023-11-24","current":-2.853944,"twenty":-11.467369,"median":-3.800488,"eighty":-3.019641,"marketCap":6050086853},{"date":"2023-12-01","current":-2.756466,"twenty":-11.417592,"median":-3.514265,"eighty":-2.990305,"marketCap":5867672174},{"date":"2023-12-08","current":-2.351787,"twenty":-11.401481,"median":-3.313885,"eighty":-2.93822,"marketCap":4986001226},{"date":"2023-12-15","current":-1.83926,"twenty":-11.309603,"median":-3.276331,"eighty":-2.913601,"marketCap":3921915598},{"date":"2023-12-22","current":-1.398202,"twenty":-11.281516,"median":-3.266894,"eighty":-2.872719,"marketCap":2979439757},{"date":"2023-12-29","current":-1.558248,"twenty":-11.205602,"median":-3.218707,"eighty":-2.860632,"marketCap":3338188625},{"date":"2024-01-05","current":-1.057644,"twenty":-11.154992,"median":-3.21182,"eighty":-2.802771,"marketCap":2249781041},{"date":"2024-01-12","current":-0.999942,"twenty":-11.150782,"median":-3.160184,"eighty":-2.759084,"marketCap":2128171255},{"date":"2024-01-19","current":-0.956974,"twenty":-11.111144,"median":-3.130992,"eighty":-2.490877,"marketCap":2033923670},{"date":"2024-01-26","current":-1.01241,"twenty":-11.026152,"median":-3.120712,"eighty":-2.309623,"marketCap":2143372478},{"date":"2024-02-02","current":-0.936815,"twenty":-10.964346,"median":-3.106604,"eighty":-1.836456,"marketCap":1980801062},{"date":"2024-02-09","current":-0.896369,"twenty":-10.938224,"median":-3.073227,"eighty":-1.544488,"marketCap":1904616406},{"date":"2024-02-16","current":-0.959266,"twenty":-10.919956,"median":-3.067843,"eighty":-1.412953,"marketCap":2038701401},{"date":"2024-02-23","current":-0.899483,"twenty":-10.863612,"median":-3.062215,"eighty":-1.31118,"marketCap":1901569020},{"date":"2024-03-01","current":-1.152465,"twenty":-10.844647,"median":-3.040182,"eighty":-1.17923,"marketCap":2437909000},{"date":"2024-03-08","current":-0.971959,"twenty":-10.843385,"median":-3.012898,"eighty":-1.152465,"marketCap":2056985718},{"date":"2024-03-15","current":-1.145767,"twenty":-10.800615,"median":-3.003359,"eighty":-1.102403,"marketCap":2422672068},{"date":"2024-03-22","current":-1.210287,"twenty":-10.775614,"median":-2.971683,"eighty":-1.108733,"marketCap":2556757063},{"date":"2024-03-28","current":-1.130651,"twenty":-10.768565,"median":-2.94471,"eighty":-1.126268,"marketCap":2404387751},{"date":"2024-04-05","current":-1.018114,"twenty":-10.746915,"median":-2.925118,"eighty":-1.078437,"marketCap":2163644237},{"date":"2024-04-12","current":-1.011803,"twenty":-10.711537,"median":-2.916466,"eighty":-1.052694,"marketCap":2151454692},{"date":"2024-04-19","current":-0.965334,"twenty":-10.642392,"median":-2.906537,"eighty":-1.046989,"marketCap":2050890946},{"date":"2024-04-26","current":-1.03546,"twenty":-10.539635,"median":-2.868164,"eighty":-1.036496,"marketCap":2197165486},{"date":"2024-05-03","current":-1.095099,"twenty":-10.513514,"median":-2.860037,"eighty":-1.038246,"marketCap":2322108322},{"date":"2024-05-10","current":-1.015083,"twenty":-10.47457,"median":-2.807837,"eighty":-1.032578,"marketCap":2157549465},{"date":"2024-05-17","current":-1.060526,"twenty":-10.460353,"median":-2.785798,"eighty":-1.029219,"marketCap":2239828893},{"date":"2024-05-24","current":-1.149726,"twenty":-10.37667,"median":-2.759739,"eighty":-1.030854,"marketCap":2422672068},{"date":"2024-05-31","current":-1.040202,"twenty":-10.309482,"median":-2.716272,"eighty":-1.030854,"marketCap":2194118100},{"date":"2024-06-07","current":-0.954703,"twenty":-10.241692,"median":-2.483148,"eighty":-1.020882,"marketCap":2011274925},{"date":"2024-06-14","current":-0.88753,"twenty":-10.223105,"median":-2.348826,"eighty":-1.015017,"marketCap":1868047771},{"date":"2024-06-21","current":-0.879235,"twenty":-9.893357,"median":-2.097181,"eighty":-1.011704,"marketCap":1846716067},{"date":"2024-06-28","current":-0.930402,"twenty":-9.799284,"median":-1.836923,"eighty":-1.004715,"marketCap":1953374586},{"date":"2024-07-05","current":-0.911731,"twenty":-9.796084,"median":-1.670031,"eighty":-0.989934,"marketCap":1913758565},{"date":"2024-07-12","current":-0.998824,"twenty":-6.512762,"median":-1.535315,"eighty":-0.975822,"marketCap":2099649126},{"date":"2024-07-19","current":-1.078316,"twenty":-4.260297,"median":-1.440488,"eighty":-0.983109,"marketCap":2266795296},{"date":"2024-07-26","current":-1.109957,"twenty":-4.076914,"median":-1.398202,"eighty":-0.988979,"marketCap":2341976752},{"date":"2024-08-02","current":-1.019736,"twenty":-3.896516,"median":-1.341466,"eighty":-0.989934,"marketCap":2150360472},{"date":"2024-08-09","current":-1.088923,"twenty":-3.792803,"median":-1.273961,"eighty":-0.992426,"marketCap":2311561470},{"date":"2024-08-16","current":-1.21024,"twenty":-3.761985,"median":-1.221942,"eighty":-0.996911,"marketCap":2570091371},{"date":"2024-08-23","current":-1.4747,"twenty":-3.613333,"median":-1.260835,"eighty":-0.999495,"marketCap":3144940210},{"date":"2024-08-30","current":-6.768747,"twenty":-3.613333,"median":-1.282548,"eighty":-1.003043,"marketCap":3899239216},{"date":"2024-09-06","current":-6.86048,"twenty":-4.076914,"median":-1.344748,"eighty":-1.005589,"marketCap":3953986725},{"date":"2024-09-13","current":-7.629828,"twenty":-6.773268,"median":-1.399159,"eighty":-1.006459,"marketCap":4385883736},{"date":"2024-09-20","current":-7.679018,"twenty":-6.86048,"median":-1.408171,"eighty":-1.008176,"marketCap":4440631245},{"date":"2024-09-27","current":-8.467696,"twenty":-7.210357,"median":-1.4747,"eighty":-1.010386,"marketCap":4926157965},{"date":"2024-10-04","current":-8.045497,"twenty":-7.438254,"median":-1.528968,"eighty":-1.010794,"marketCap":4659279943},{"date":"2024-10-10","current":-6.916807,"twenty":-7.445917,"median":-1.535454,"eighty":-1.011308,"marketCap":3979699659},{"date":"2024-10-18","current":-6.535297,"twenty":-7.4076,"median":-1.599022,"eighty":-1.011803,"marketCap":3740585295},{"date":"2024-10-25","current":-6.87674,"twenty":-7.395,"median":-1.716627,"eighty":-1.011971,"marketCap":3935766258},{"date":"2024-11-01","current":-6.487355,"twenty":-7.390607,"median":-1.836923,"eighty":-1.01241,"marketCap":3715412316},{"date":"2024-11-08","current":-5.268552,"twenty":-7.067714,"median":-2.097181,"eighty":-1.012524,"marketCap":2994521565},{"date":"2024-11-15","current":-4.934518,"twenty":-6.939983,"median":-2.348826,"eighty":-1.014752,"marketCap":2783467441},{"date":"2024-11-22","current":-4.525008,"twenty":-6.921031,"median":-2.487824,"eighty":-1.015083,"marketCap":2551002028},{"date":"2024-11-29","current":-4.212716,"twenty":-6.916807,"median":-2.719501,"eighty":-1.015704,"marketCap":2373594213},{"date":"2024-12-06","current":-4.301808,"twenty":-6.905598,"median":-2.763011,"eighty":-1.018114,"marketCap":2418082775},{"date":"2024-12-13","current":-4.02776,"twenty":-6.88455,"median":-2.792596,"eighty":-1.019736,"marketCap":2261974665},{"date":"2024-12-20","current":-3.895979,"twenty":-6.880216,"median":-2.853944,"eighty":-1.020882,"marketCap":2175955910},{"date":"2024-12-27","current":-3.693493,"twenty":-6.879252,"median":-2.860037,"eighty":-1.021555,"marketCap":2061264237},{"date":"2025-01-03","current":-3.393321,"twenty":-6.877861,"median":-2.868164,"eighty":-1.023476,"marketCap":1895598486},{"date":"2025-01-10","current":-2.994045,"twenty":-6.870236,"median":-2.906537,"eighty":-1.026058,"marketCap":1666215140},{"date":"2025-01-17","current":-2.591221,"twenty":-6.86048,"median":-2.868164,"eighty":-1.027008,"marketCap":1443203553},{"date":"2025-01-24","current":-2.296545,"twenty":-6.833199,"median":-2.860899,"eighty":-1.028243,"marketCap":1287095443},{"date":"2025-01-28","current":-2.466671,"twenty":-6.805918,"median":-2.857066,"eighty":-1.028894,"marketCap":1389043597},{"date":"2025-02-07","current":-2.798033,"twenty":-6.785996,"median":-2.820002,"eighty":-1.030527,"marketCap":1567452866},{"date":"2025-02-14","current":-3.403301,"twenty":-6.780924,"median":-2.832166,"eighty":-1.031664,"marketCap":1901970246},{"date":"2025-02-21","current":-2.965189,"twenty":-6.771007,"median":-2.858982,"eighty":-1.034711,"marketCap":1666215140},{"date":"2025-02-28","current":-3.128579,"twenty":-6.737748,"median":-2.857066,"eighty":-1.035452,"marketCap":1752233895},{"date":"2025-03-07","current":-3.795937,"twenty":-6.685693,"median":-2.863309,"eighty":-1.035834,"marketCap":2134539472},{"date":"2025-03-14","current":-3.17157,"twenty":-6.632156,"median":-2.878989,"eighty":-1.03679,"marketCap":1784092693},{"date":"2025-03-21","current":-3.342788,"twenty":-6.586773,"median":-2.907899,"eighty":-1.03784,"marketCap":1879669087},{"date":"2025-03-28","current":-4.261325,"twenty":-6.543854,"median":-2.91933,"eighty":-1.038839,"marketCap":1978431362},{"date":"2025-04-03","current":-3.930581,"twenty":-6.51804,"median":-2.925118,"eighty":-1.039278,"marketCap":1825509131},{"date":"2025-04-11","current":-3.073189,"twenty":-6.495027,"median":-2.922242,"eighty":-1.03967,"marketCap":1414530635},{"date":"2025-04-17","current":-3.165897,"twenty":-6.47136,"median":-2.94471,"eighty":-1.039975,"marketCap":1459132952},{"date":"2025-04-25","current":-3.918674,"twenty":-6.44197,"median":-2.955046,"eighty":-1.041501,"marketCap":1809579732},{"date":"2025-05-02","current":-4.151319,"twenty":-6.420376,"median":-2.965975,"eighty":-1.046698,"marketCap":1921085525},{"date":"2025-05-09","current":-4.238599,"twenty":-6.416374,"median":-2.989735,"eighty":-1.04728,"marketCap":1975245482},{"date":"2025-05-13","current":-4.160585,"twenty":-6.412794,"median":-2.992175,"eighty":-1.047676,"marketCap":1952944323}],"updateTime":1747258782964}}}